Bai-fang Wang, Bing-yuan Wang, Ying Wang, Bo Wen, Shu Liu, L. Sang, Yushuai Chen, Dai Zhang
{"title":"Association of APPL1 Gene Polymorphism with Non-Alcoholic Fatty Liver Disease Susceptibility in a Chinese Han Population.","authors":"Bai-fang Wang, Bing-yuan Wang, Ying Wang, Bo Wen, Shu Liu, L. Sang, Yushuai Chen, Dai Zhang","doi":"10.7754/CLIN.LAB.2015.150417","DOIUrl":null,"url":null,"abstract":"BACKGROUND The adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 (APPL1) has been suggested to play an important role in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). The aim of this article is to explore the relationship between APPL1 rs4640525 polymorphism and the susceptibility of NAFLD in a Chinese Han population. METHODS In this study, rs4640525, a significant single nucleotide polymorphism, in the APPL1 gene was detected by the polymerase chain reaction-restriction fragment length polymorphism method, followed by extracting genomic DNA from peripheral blood leukocytes from patients with NAFLD (n = 280) and matched controls (n = 281). RESULTS The frequency of both the GG genotype and the G carrier (CG+GG) genotype were higher in NAFLD subjects compared with control subjects (all p < 0.05). The G allele frequency was 0.3036 in the NAFLD group and 0.2206 in the control group, showing a significant difference (p < 0.05). What is more, multivariate logistic regression analysis suggested that the GG genotype, G carrier genotype, body mass index, waist circumference, white blood cells, total cholesterol, alanine aminotransferase, and γ-glutamyl-transferase might be associated with an increased susceptibility of NAFLD (all p < 0.05). CONCLUSIONS The article provides evidence that GG genotype and G carrier (CG+GG) genotypes of the rs4640525 polymorphism in the APPL1 gene may be suitable susceptibility biomarkers for NAFLD.","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"61 11 1","pages":"1659-66"},"PeriodicalIF":0.6000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical laboratory","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7754/CLIN.LAB.2015.150417","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 7
Abstract
BACKGROUND The adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 (APPL1) has been suggested to play an important role in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). The aim of this article is to explore the relationship between APPL1 rs4640525 polymorphism and the susceptibility of NAFLD in a Chinese Han population. METHODS In this study, rs4640525, a significant single nucleotide polymorphism, in the APPL1 gene was detected by the polymerase chain reaction-restriction fragment length polymorphism method, followed by extracting genomic DNA from peripheral blood leukocytes from patients with NAFLD (n = 280) and matched controls (n = 281). RESULTS The frequency of both the GG genotype and the G carrier (CG+GG) genotype were higher in NAFLD subjects compared with control subjects (all p < 0.05). The G allele frequency was 0.3036 in the NAFLD group and 0.2206 in the control group, showing a significant difference (p < 0.05). What is more, multivariate logistic regression analysis suggested that the GG genotype, G carrier genotype, body mass index, waist circumference, white blood cells, total cholesterol, alanine aminotransferase, and γ-glutamyl-transferase might be associated with an increased susceptibility of NAFLD (all p < 0.05). CONCLUSIONS The article provides evidence that GG genotype and G carrier (CG+GG) genotypes of the rs4640525 polymorphism in the APPL1 gene may be suitable susceptibility biomarkers for NAFLD.
期刊介绍:
Clinical Laboratory is an international fully peer-reviewed journal covering all aspects of laboratory medicine and transfusion medicine. In addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies. The journal publishes original articles, review articles, posters, short reports, case studies and letters to the editor dealing with 1) the scientific background, implementation and diagnostic significance of laboratory methods employed in hospitals, blood banks and physicians'' offices and with 2) scientific, administrative and clinical aspects of transfusion medicine and 3) in addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies.